Spirocyclic NK1 antagonists I:: [4.5] and [5.5]-spiroketals

被引：25
|
作者：
Seward, EM
Carlson, E
Harrison, T
Haworth, KE
Herbert, R
Kelleher, FJ
Kurtz, MM
Moseley, J
Owen, SN
Owens, AP
Sadowski, SJ
Swain, CJ
Williams, BJ
机构：
[1] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow, Essex, England
[2] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow, Essex, England
[3] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 18期
关键词：
D O I：
10.1016/S0960-894X(02)00506-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel spiroketal-based NK1 antagonists is described. The effect of modifications to the spiroether ring and aromatic substituents are discussed, leading to the identification of compounds with high affinity and excellent CNS penetration. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2515 / 2518
页数：4
相关论文
共 50 条
  • [21] Cyclic urea derivatives as potent NK1 selective antagonists
    Shue, HJ
    Chen, X
    Shih, NY
    Blythin, DJ
    Paliwal, S
    Lin, L
    Gu, DL
    Schwerdt, JH
    Shah, S
    Reichard, GA
    Piwinski, JJ
    Duffy, RA
    Lachowicz, JE
    Coffin, VL
    Liu, F
    Nomeir, AA
    Morgan, CA
    Varty, GB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (17) : 3896 - 3899
  • [22] Potentiating antidepressant strategy: focus on NK1 receptor antagonists
    Guiard, BP
    Gardier, AM
    Blier, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S31 - S32
  • [23] Gut feelings about tachykinin NK1 receptor antagonists
    Laird, J
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (04) : 169 - 169
  • [24] NK1 antagonists based on seven membered lactam scaffolds
    Elliott, JM
    Carlson, EJ
    Chicchi, GG
    Dirat, O
    Dominguez, M
    Gerhard, U
    Jelley, R
    Jones, AB
    Kurtz, MM
    Tsao, KI
    Wheeldon, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2571 - U2572
  • [25] QUINUCLIDINE-BASED NK1 ANTAGONISTS, THE ROLE OF THE BENZHYDRYL
    SWAIN, CJ
    FONG, TM
    HAWORTH, K
    OWEN, SN
    SEWARD, EM
    STRADER, CD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (12) : 1261 - 1264
  • [26] Emerging targets for cough therapies; NK1 receptor antagonists
    Badri, Huda
    Smith, Jaclyn A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 59
  • [27] Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists
    Mah, R
    Gerspacher, M
    von Sprecher, A
    Stutz, S
    Tschinke, V
    Anderson, GP
    Bertrand, C
    Subramanian, N
    Ball, HA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) : 2065 - 2068
  • [28] Discovery of novel, orally active dual NK1/NK2 antagonists
    Bernstein, PR
    Aharony, D
    Albert, JS
    Andisik, D
    Barthlow, HG
    Bialecki, R
    Davenport, T
    Dedinas, RF
    Dembofsky, BT
    Koether, G
    Kosmider, BJ
    Kirkland, K
    Ohnmacht, CJ
    Potts, W
    Rumsey, WL
    Shen, LH
    Shenvi, A
    Sherwood, S
    Stollman, D
    Russell, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2769 - 2773
  • [29] Design and synthesis of potential dual NK1/NK3 receptor antagonists
    Hanessian, Stephen
    Babonneau, Vincent
    Boyer, Nicolas
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    De Nanteuil, Guillaume
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (02) : 510 - 514
  • [30] Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors
    Engberg, Susanna
    Ahistedt, Ingela
    Leffler, Agnes
    Lindstrom, Erik
    Kristensson, Elin
    Svensson, Arne
    Pahman, Ingrid
    Johansson, Anders
    Drmota, Tomas
    von Mentzer, Bengt
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (02) : 259 - 269
12345